AULNX
Price
$110.03
Change
-$0.05 (-0.05%)
Updated
Aug 7 closing price
Net Assets
26.36B
GFACX
Price
$71.52
Change
+$0.63 (+0.89%)
Updated
Aug 6 closing price
Net Assets
324.74B
Interact to see
Advertisement

AULNX vs GFACX

Header iconAULNX vs GFACX Comparison
Open Charts AULNX vs GFACXBanner chart's image
American Century Ultra® G
Price$110.03
Change-$0.05 (-0.05%)
VolumeN/A
Net Assets26.36B
American Funds Growth Fund of Amer C
Price$71.52
Change+$0.63 (+0.89%)
VolumeN/A
Net Assets324.74B
AULNX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AULNX vs. GFACX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AULNX is a Buy and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 325B vs. AULNX (26.4B). AULNX (0.00) and GFACX (0.00) have matching dividends . AULNX was incepted earlier than GFACX: AULNX (6 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than AULNX (0.57). GFACX is a more actively managed with annual turnover of: 25.00 vs. AULNX (7.00). AULNX has a lower initial minimum investment than GFACX: AULNX (0) vs GFACX (250). AULNX annual gain was more profitable for investors over the last year : 21.66 vs. GFACX (18.41). AULNX return over 5 years is better than : 56.47 vs. GFACX (33.13).
AULNXGFACXAULNX / GFACX
Total Expense Ratio0.001.36-
Annual Report Gross Expense Ratio0.571.3642%
Fund Existence6 years24 years-
Gain YTD5.39012.17144%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets26.4B325B8%
Annual Yield % from dividends0.000.00-
Returns for 1 year21.6618.41118%
Returns for 3 years45.1539.63114%
Returns for 5 years56.4733.13170%
Returns for 10 yearsN/A67.85-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPRO2.260.14
+6.60%
Spero Therapeutics
UXIN3.830.11
+2.96%
Uxin Limited
CCRN13.100.26
+2.02%
Cross Country Healthcare
GBDC14.78-0.01
-0.07%
Golub Capital BDC
CRBG34.23-0.07
-0.20%
Corebridge Financial